Braden Michael Leonard Gemini Therapeutics, Inc. (GMTX) insider trading activity

Braden Michael Leonard is > 10% Shareholder of Gemini Therapeutics, Inc. . Currently has a direct ownership of 247,500 shares of GMTX, which is worth approximately $6.03 Million. The most recent transaction as insider was on Oct 26, 2022, when has been sold 22,500 shares (Common Stock) at a price of $2.09 per share, resulting in proceeds of $47,025. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 248K

0% 3M change

0% 12M change

Total Value Held $6.03 Million

Braden Michael Leonard Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 26 2022	SELL Open market or private sale	$47,025 $2.09 p/Share	22,500 Reduced 8.33%	247,500 Common Stock
Apr 12 2022	BUY Open market or private purchase	$74,800 $1.36 p/Share	55,000 Added 16.92%	270,000 Common Stock

Also insider at

IMRA

IMARA Inc. Healthcare

> 10% Shareholder

RVP

RETRACTABLE TECHNOLOGIES INC Healthcare

> 10% Shareholder

ASTC

ASTROTECH Corp Industrials

> 10% Shareholder

MTCR

Metacrine, Inc. Healthcare

> 10% Shareholder

STSA

Satsuma Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

CYT

Cyteir Therapeutics, Inc. Healthcare

AVRO

AVROBIO, Inc. Healthcare

RPHM

Reneo Pharmaceuticals, Inc. Healthcare

ACRS

Aclaris Therapeutics, Inc. Healthcare

ADVM

Adverum Biotechnologies, Inc. Healthcare

ANTX

AN2 Therapeutics, Inc. Healthcare

TLIS

Talis Biomedical Corp Healthcare

BML